Author Correction: Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants

Sci Rep. 2022 Oct 3;12(1):16540. doi: 10.1038/s41598-022-20913-1.

¹ Department of BioNano Technology, Gachon University, Seongnam, Republic of Korea.
² Department of Microbiology, Institute for Viral Diseases, Chung Mong-Koo Vaccine Innovation Center, College of Medicine, Korea University, 73 Goryeodae-ro, Seongbuk-gu, Seoul, 02841, Republic of Korea.
³ Department of Microbiology and Immunology, Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, 03722, Korea.
⁴ Department of Microbiology, Institute for Viral Diseases, Chung Mong-Koo Vaccine Innovation Center, College of Medicine, Korea University, 73 Goryeodae-ro, Seongbuk-gu, Seoul, 02841, Republic of Korea. ms0392@korea.ac.kr.
⁵ Department of BioNano Technology, Gachon University, Seongnam, Republic of Korea. pa90201@gachon.ac.kr.

^# Contributed equally.

No abstract available

Publication types